+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Preeclampsia Laboratory Testing Market - Global Industry Analysis (2017 - 2019) - Growth Trends and Market Forecast (2020 - 2025)

  • ID: 5327512
  • Report
  • April 2021
  • Region: Global
  • 145 Pages
  • Fairfield Market Research

FEATURED COMPANIES

  • Bayer AG,
  • DiabetOmics Inc.,
  • DRG INSTRUMENTS GMBH
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Progenity Inc.
The global preeclampsia laboratory testing market was worth US$ 1.24 billion in 2020 and is poised to grow at a healthy rate for the forecast period from 2020 -2025. The preeclampsia laboratory testing market should benefit primarily from two factors - a high prevalence of preeclampsia in developing countries, coupled with several product launches to cater to this surging caseload. As per the latest insights, the preeclampsia laboratory testing market will grow by double digits during the assessment period, making it critical for organizations to secure their long-term prospects.

Highlights of Preeclampsia Laboratory Testing Market:
  • Blood tests are anticipated to remain the leading test category for the foreseeable future
  • In terms of revenue, North America leads the global preeclampsia laboratory testing market
  • A few companies profiled in the preeclampsia laboratory testing market comprise Bayer AG, SERA Prognostics, Siemens Healthineers, and DRG Instruments GMBH
  • Several challenges such as delayed healthcare access, delivery, inadequate implementation, and poor policy guidelines stifle the growth of the preeclampsia laboratory testing market
Three Companies Dominate the Global Preeclampsia Laboratory Testing Market

ThermoFischer Scientific, F. Hoffmann-La Roche, and PerkinElmer have approx. 60% of the global preeclampsia laboratory testing market amongst themselves. Along with these companies, the exhaustive report has also analyzed SERA Prognostics, Bayer AG, Siemens Healthineers AG, Metabolomic Diagnostics Ltd., DiabetOmics Inc., DRG INSTRUMENTS GMBH, and Progenity Inc, amongst others.

Blood Tests the Preferred Test Type in Preeclampsia Laboratory Testing Market

Blood tests hold a sizeable lead in the test type category of the preeclampsia laboratory testing market and this is not projected to change anytime soon. Patients opt for blood tests over other options because of their higher accuracy rates. Furthermore, several novel biomarkers have been launched in the preeclampsia laboratory testing market recently.

Challenging Conditions for Major Stakeholders in Preeclampsia Laboratory Testing Market

A number of constraints inhibit the growth of the global preeclampsia laboratory testing market. The most common ones include slow decision making, delayed access to healthcare, deficient policy guidelines, and improper implementation at both micro and macro levels. This burden is particularly acute in developing countries, where medical interventions are usually ineffective due to a late diagnosis of preeclampsia. An absence of cost-effective preeclampsia screen options, along with an overall lack of awareness in emerging economies, will be the primary challenge that all stakeholders in the preeclampsia laboratory testing market will have to overcome.

North America Holds the Key to Profitability in Preeclampsia Laboratory Testing Market

North America plays a preeminent role in the global preeclampsia laboratory testing market as it is the largest revenue contributor. The North American region was worth US$ 465 million in 2020 alone, and is predicted to grow at a healthy CAGR of 9.6% until 2025. The reasons are twofold - the presence of numerous patient advocacy groups as well as government initiatives to develop a better diagnostics regimen. In 2019, the Food & Drug Association (FDA) approved an advanced prenatal therapeutics (APT) device designation to treat Targeted Apheresis Column for Preeclampsia (TAC-PE).

High Economic Burden Boosts Prospects of Preeclampsia Laboratory Testing Market

The Ethiopian National Emergency Obstetric and Newborn Care states that 10% of maternal mortality is linked to preeclampsia. In India, the incidence of preeclampsia is estimated to be within the range of 8-10%. This problem is not restricted to developing countries alone as the Preeclampsia Foundation states that preeclampsia-related short-term costs are around US$ 2 billion in the U.S. alone.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG,
  • DiabetOmics Inc.,
  • DRG INSTRUMENTS GMBH
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Progenity Inc.
1. Executive Summary
1.1. Global Preeclampsia Laboratory Testing Market Outlook, 2017 - 2025 (US$ Million)
1.2. Global Preeclampsia Laboratory Testing Market Incremental Opportunity, 2020 - 2025 (US$ Million)
1.3. Key Industry Trends

2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Market Drivers
2.2.2. Market Restraints
2.3. Preeclampsia Epidemiology
2.4. Regulatory Guidelines

3. Global Preeclampsia Laboratory Testing Market Outlook, 2017-2025
3.1. Global Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
3.1.1. Key Highlights
3.1.2. Global Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
3.1.2.1. Blood Tests
3.1.2.2. Urine Tests
3.1.3. Global Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
3.1.4. Global Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
3.2. Global Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
3.2.1. Key Highlights
3.2.2. Global Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
3.2.2.1. Consumables
3.2.2.2. Instruments
3.2.3. Global Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
3.2.4. Global Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
3.3. Global Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
3.3.1. Key Highlights
3.3.2. Global Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
3.3.2.1. Hospitals & Clinics
3.3.2.2. Diagnostics Centers
3.3.2.3. Others
3.3.3. Global Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
3.3.4. Global Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
3.4. Global Preeclampsia Laboratory Testing Market Outlook, By Region, 2017-2025
3.4.1. Key Highlights
3.4.2. Global Preeclampsia Laboratory Testing Market Outlook, by Region, Value (US$ Million), 2017 - 2025
3.4.2.1. North America
3.4.2.2. Europe
3.4.2.3. Asia Pacific
3.4.2.4. Latin America
3.4.2.5. Middle East & Africa
3.4.3. Global Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Region, 2020 and 2025
3.4.4. Global Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Region, 2020-2025

4. North America Preeclampsia Laboratory Testing Market Outlook, 2017-2025
4.1. North America Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
4.1.1. Key Highlights
4.1.2. North America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
4.1.2.1. Blood Tests
4.1.2.2. Urine Tests
4.1.3. North America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
4.1.4. North America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
4.2. North America Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
4.2.1. Key Highlights
4.2.2. North America Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
4.2.2.1. Consumables
4.2.2.2. Instruments
4.2.3. North America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
4.2.4. North America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
4.3. North America Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
4.3.1. Key Highlights
4.3.2. North America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
4.3.2.1. Hospitals & Clinics
4.3.2.2. Diagnostics Centers
4.3.2.3. Others
4.3.3. North America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
4.3.4. North America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
4.4. North America Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
4.4.1. Key Highlights
4.4.2. North America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
4.4.2.1. United States
4.4.2.2. Canada
4.4.3. North America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
4.4.4. North America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

5. Europe Preeclampsia Laboratory Testing Market Outlook, 2017-2025
5.1. Europe Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
5.1.1. Key Highlights
5.1.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
5.1.2.1. Blood Tests
5.1.2.2. Urine Tests
5.1.3. Europe Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
5.1.4. Europe Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
5.2. Europe Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
5.2.1. Key Highlights
5.2.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
5.2.2.1. Consumables
5.2.2.2. Instruments
5.2.3. Europe Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
5.2.4. Europe Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
5.3. Europe Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
5.3.1. Key Highlights
5.3.2. Europe Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
5.3.2.1. Hospitals & Clinics
5.3.2.2. Diagnostics Centers
5.3.2.3. Others
5.3.3. Europe Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
5.3.4. Europe Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
5.4. Europe Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
5.4.1. Key Highlights
5.4.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
5.4.2.1. Germany
5.4.2.2. France
5.4.2.3. United Kingdom
5.4.2.4. Italy
5.4.2.5. Spain
5.4.2.6. Scandinavia
5.4.2.7. Rest of Europe
5.4.3. Europe Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
5.4.4. Europe Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

6. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, 2017-2025
6.1. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
6.1.1. Key Highlights
6.1.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
6.1.2.1. Blood Tests
6.1.2.2. Urine Tests
6.1.3. Asia Pacific Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
6.1.4. Asia Pacific Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
6.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
6.2.1. Key Highlights
6.2.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
6.2.2.1. Consumables
6.2.2.2. Instruments
6.2.3. Asia Pacific Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
6.2.4. Asia Pacific Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
6.3. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
6.3.1. Key Highlights
6.3.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
6.3.2.1. Hospitals & Clinics
6.3.2.2. Diagnostics Centers
6.3.2.3. Others
6.3.3. Asia Pacific Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
6.3.4. Asia Pacific Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
6.4. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
6.4.1. Key Highlights
6.4.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
6.4.2.1. Japan
6.4.2.2. China
6.4.2.3. India
6.4.2.4. Australia & New Zealand
6.4.2.5. South East Asia
6.4.2.6. Rest of Asia Pacific
6.4.3. Asia Pacific Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
6.4.4. Asia Pacific Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

7. Latin America Preeclampsia Laboratory Testing Market Outlook, 2017-2025
7.1. Latin America Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
7.1.1. Key Highlights
7.1.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
7.1.2.1. Blood Tests
7.1.2.2. Urine Tests
7.1.3. Latin America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
7.1.4. Latin America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
7.2. Latin America Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
7.2.1. Key Highlights
7.2.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
7.2.2.1. Consumables
7.2.2.2. Instruments
7.2.3. Latin America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
7.2.4. Latin America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
7.3. Latin America Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
7.3.1. Key Highlights
7.3.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
7.3.2.1. Hospitals & Clinics
7.3.2.2. Diagnostics Centers
7.3.2.3. Others
7.3.3. Latin America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
7.3.4. Latin America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
7.4. Latin America Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
7.4.1. Key Highlights
7.4.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
7.4.2.1. Brazil
7.4.2.2. Mexico
7.4.2.3. Rest of Latin America
7.4.3. Latin America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
7.4.4. Latin America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

8. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, 2017-2025
8.1. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
8.1.1. Key Highlights
8.1.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
8.1.2.1. Blood Tests
8.1.2.2. Urine Tests
8.1.3. Middle East & Africa Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
8.1.4. Middle East & Africa Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
8.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
8.2.1. Key Highlights
8.2.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
8.2.2.1. Consumables
8.2.2.2. Instruments
8.2.3. Middle East & Africa Share and BPS Analysis, by Product, 2020 and 2025
8.2.4. Middle East & Africa Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
8.3. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
8.3.1. Key Highlights
8.3.1. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
8.3.1.1. Hospitals & Clinics
8.3.1.2. Diagnostics Centers
8.3.1.3. Others
8.3.2. Middle East & Africa Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
8.3.3. Middle East & Africa Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
8.4. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
8.4.1. Key Highlights
8.4.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
8.4.2.1. GCC Countries
8.4.2.2. South Africa
8.4.2.3. Rest of Middle East & Africa
8.4.3. Middle East & Africa Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
8.4.4. Middle East & Africa Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

9. Competitive Landscape
9.1. Top 15 Company Market Share Analysis, 2019
9.2. Strategic Collaborations
9.3. Company Profiles
9.3.1. PerkinElmer Inc.
9.3.1.1. Company overview
9.3.1.2. Financial performance
9.3.1.3. Test Type Portfolio
9.3.1.4. Recent Developments
9.3.2. F. Hoffmann-La Roche Ltd.
9.3.3. ThermoFischer Scientific Inc.
9.3.4. SERA Prognostics
9.3.5. Bayer AG,
9.3.6. Siemens Healthineers AG
9.3.7. Metabolomic Diagnostics Ltd.
9.3.8. DiabetOmics Inc.,
9.3.9. DRG INSTRUMENTS GMBH
9.3.10. Progenity Inc.

10. Appendix
10.1. Research Methodology
10.2. Report Specific Research Approach
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • PerkinElmer Inc.
  • F. Hoffmann-La Roche Ltd.
  • ThermoFischer Scientific Inc.
  • SERA Prognostics
  • Bayer AG,
  • Siemens Healthineers AG
  • Metabolomic Diagnostics Ltd.
  • DiabetOmics Inc.,
  • DRG INSTRUMENTS GMBH
  • Progenity Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll